tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ERAS Stock Latest News

Erasca price target raised to $11 from $3 at Clear Street
The FlyErasca price target raised to $11 from $3 at Clear Street
24h ago
ERAS
Erasca announces ‘promising’ early clinical data for ERAS-0015
PremiumThe Fly
Erasca announces ‘promising’ early clinical data for ERAS-0015
1d ago
ERAS
Erasca Highlights Accelerated Progress in RAS-Targeted Trials
PremiumCompany Announcements
Erasca Highlights Accelerated Progress in RAS-Targeted Trials
1d ago
8K
ERAS
Erasca Inc trading resumes
PremiumThe Fly
Erasca Inc trading resumes
5d ago
ERAS
Erasca Inc trading halted, volatility trading pause
PremiumThe Fly
Erasca Inc trading halted, volatility trading pause
5d ago
ERAS
Erasca jumps 22% after report on Merck talks for rival Revolution
PremiumThe FlyErasca jumps 22% after report on Merck talks for rival Revolution
5d ago
MRK
ERAS
Erasca price target raised to $4 from $2 at Morgan Stanley
Premium
The Fly
Erasca price target raised to $4 from $2 at Morgan Stanley
5d ago
ERAS
Erasca up 66% after WSJ report on AbbVie interest in Revolution Medicines
Premium
The Fly
Erasca up 66% after WSJ report on AbbVie interest in Revolution Medicines
6d ago
ABBV
ERAS
Erasca initiated with an Overweight at Piper Sandler
PremiumThe Fly
Erasca initiated with an Overweight at Piper Sandler
7d ago
ERAS
RVMD
Erasca price target raised to $2 from $1 at BofA
PremiumThe Fly
Erasca price target raised to $2 from $1 at BofA
7d ago
ERAS
Erasca price target raised to $5 from $4 at Mizuho
PremiumThe Fly
Erasca price target raised to $5 from $4 at Mizuho
1M ago
ERAS
Erasca price target raised to $5 from $3 at Guggenheim
PremiumThe Fly
Erasca price target raised to $5 from $3 at Guggenheim
2M ago
ERAS
Erasca, Inc. Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsErasca, Inc. Reports Q3 2025 Financial Results
2M ago
ERAS
Erasca reports Q3 EPS (11c), consensus (10c)
Premium
The Fly
Erasca reports Q3 EPS (11c), consensus (10c)
2M ago
ERAS
Erasca price target raised to $6 from $4 at Stifel
Premium
The Fly
Erasca price target raised to $6 from $4 at Stifel
2M ago
ERAS
RVMD
Erasca announces issuance of U.S. patent covering ERAS-0015
PremiumThe Fly
Erasca announces issuance of U.S. patent covering ERAS-0015
2M ago
ERAS
Erasca, Inc. Advances with Promising Phase 1 Study on ERAS-4001
PremiumCompany Announcements
Erasca, Inc. Advances with Promising Phase 1 Study on ERAS-4001
3M ago
ERAS
Erasca, Inc. Advances in Cancer Treatment with ERAS-0015 Study
PremiumCompany Announcements
Erasca, Inc. Advances in Cancer Treatment with ERAS-0015 Study
3M ago
ERAS
Erasca’s SEACRAFT-2 Study: A Promising Step in Melanoma Treatment
PremiumCompany Announcements
Erasca’s SEACRAFT-2 Study: A Promising Step in Melanoma Treatment
3M ago
ERAS
Erasca’s Strategic Positioning and Growth Potential in the RAS Inhibitor Market: Analyst Recommends ‘Buy’ with $4 Price Target
PremiumRatingsErasca’s Strategic Positioning and Growth Potential in the RAS Inhibitor Market: Analyst Recommends ‘Buy’ with $4 Price Target
3M ago
ERAS
Erasca initiated with a Buy at Stifel
Premium
The Fly
Erasca initiated with a Buy at Stifel
3M ago
ERAS
RVMD
Unusually active option classes on open October 8th
Premium
The Fly
Unusually active option classes on open October 8th
3M ago
AA
AGQ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >